Qualitative and Quantitative Assessment of Drug-Drug Interaction Potential in Man, Based on Ki, IC50 and Inhibitor Concentration

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|5|2|147-156

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.5, Iss.2, 2004-04, pp. : 147-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug-Drug Interaction Prediction Assessment

By Zhou Jihao

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 641-657

Taylor & Francis Ltd

Access to resources Recommend Favorite

Thienopyridines and Statins: Assessing a Potential Drug-Drug Interaction

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1271-1280

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic drug–drug interaction assessment between LCZ696, an angiotensin receptor neprilysin inhibitor, and hydrochlorothiazide, amlodipine, or carvedilol

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 6, 2015-11 ,pp. : 407-417

John Wiley & Sons Inc

Access to resources Recommend Favorite

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

By Miners John O. Mackenzie Peter I. Knights Kathleen M.

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 196-208

Informa Healthcare

Access to resources Recommend Favorite

Determinants of potential drug–drug interaction associated dispensing in community pharmacies in the Netherlands

By Becker Matthijs Caspers Peter Kallewaard Marjon Bruinink Riekert Kylstra Nico Heisterkamp Siem Valk Vincent Veen André Stricker Bruno

Pharmacy World and Science, Vol. 29, Iss. 2, 2007-04 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite